Skip to main content
# Title Department Research Year
101 Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties Department of Pharmaceutical Organic Chemistry 2022
102 Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 complex from SARS-CoV-2. 2022
103 Microwave-Assisted Synthesis, Biological Activity Evaluation, Molecular Docking, and ADMET Studies of Some Novel Pyrrolo [2,3-b] Pyrrole Derivatives Department of Medicinal Chemistry 2022
104 Elegant, Flexible Vesicular Nanocarriers for the Efficient Skin Delivery of Topically Applied Drugs Department of Pharmaceutics 2022
105 Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAFV600E 2022
106 Nanocomposite of gold nanoparticles@nickel disulfide-plant derived carbon for molecularly imprinted electrochemical determination of favipiravir Department of Pharmaceutical Analytical Chemistry 2022
107 THE INHIBITORY EFFECT OF DOUM PALM (HYPHAENE THEBAICA L. MART.) LEAVES EXTRACT ON α-GLUCOSIDASE ACTIVITY Department of Pharmacognosy 2022
108 Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity 2022
109 Nucleic acids for gene therapy (book chapter) Department of Pharmaceutics 2022
110 Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway Department of Pharmaceutical Organic Chemistry 2022